March 24, 2025 - 10:28

Asian shares experienced a downward trend on Monday, following a significant rebound in technology stocks that helped Wall Street break a four-week losing streak. Investors in the region are closely monitoring the implications of U.S. trade policies, particularly those initiated by President Donald Trump.
U.S. stock futures showed signs of improvement as market participants awaited further clarity on the administration's tariff strategies. Recent reports indicated that President Trump might refine his approach, potentially concentrating on countries that maintain substantial trade surpluses with the United States, many of which are located in Asia.
The looming deadline of April 2 for the implementation of additional tariffs on trading partners adds to the uncertainty. As traders digest these developments, the potential impact on global trade dynamics and market stability remains a focal point for investors in the Asian markets. The overall sentiment reflects caution as the region navigates the complex landscape of international trade relations.
May 17, 2026 - 08:31
How Investors Are Reacting To NVE (NVEC) Steady Earnings And Maintained Quarterly DividendNVE Corporation has released its full-year results for the period ending March 31, 2026, posting revenue of US$26.33 million and net income of US$15.2 million. The company also confirmed a...
May 16, 2026 - 22:25
Risky Integration or Rewarding Returns? The Stakes of SoundHound's LivePerson Acquisition.SoundHound AI`s acquisition of LivePerson is drawing mixed reactions from investors, with the immediate fallout hitting the stock price. The deal, which combines SoundHound`s voice AI technology...
May 16, 2026 - 10:38
Bank of Hawaii, Glacier Bancorp, and Wintrust Financial Shares Plummet, What You Need To KnowShares of several regional banks took a sharp hit in afternoon trading Wednesday after the latest inflation report came in hotter than expected. The April Consumer Price Index rose 3.8%, a figure...
May 15, 2026 - 17:39
Plus Therapeutics Shares First Quarter 2026 Financial Results and Updates on REYOBIQ and CNSide ProgressHOUSTON, May 15, 2026 -- Plus Therapeutics, a healthcare company focused on precision diagnostics and radiopharmaceuticals for central nervous system cancers, reported its financial results for the...